HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,871,736 | +12.1% | 258,205 | -0.3% | 0.07% | +18.6% |
| Q2 2023 | $26,644,836 | -4.7% | 259,065 | +1.2% | 0.06% | -9.2% |
| Q1 2023 | $27,951,409 | -5.2% | 256,106 | -1.2% | 0.06% | -9.7% |
| Q4 2022 | $29,490,815 | +74.5% | 259,146 | -5.1% | 0.07% | +67.4% |
| Q3 2022 | $16,903,000 | -21.0% | 273,106 | +1.9% | 0.04% | -17.3% |
| Q2 2022 | $21,387,000 | -22.5% | 268,141 | +2.2% | 0.05% | -1.9% |
| Q1 2022 | $27,613,000 | -2.9% | 262,458 | -0.6% | 0.05% | +3.9% |
| Q4 2021 | $28,445,000 | -2.1% | 263,970 | -0.5% | 0.05% | -10.5% |
| Q3 2021 | $29,056,000 | +15.7% | 265,255 | -1.1% | 0.06% | +21.3% |
| Q2 2021 | $25,120,000 | +13.4% | 268,265 | +11.4% | 0.05% | +6.8% |
| Q1 2021 | $22,160,000 | +22.3% | 240,761 | -2.8% | 0.04% | +18.9% |
| Q4 2020 | $18,114,000 | +6.9% | 247,625 | +13.5% | 0.04% | -5.1% |
| Q3 2020 | $16,947,000 | +43.4% | 218,170 | +2.6% | 0.04% | +34.5% |
| Q2 2020 | $11,819,000 | +105.4% | 212,641 | +9.5% | 0.03% | +70.6% |
| Q1 2020 | $5,753,000 | -7.3% | 194,235 | +13.3% | 0.02% | +13.3% |
| Q4 2019 | $6,207,000 | +175.7% | 171,474 | +107.4% | 0.02% | +150.0% |
| Q3 2019 | $2,251,000 | +21.0% | 82,674 | +6.9% | 0.01% | +20.0% |
| Q2 2019 | $1,860,000 | – | 77,314 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |